Detalles de la búsqueda
1.
Role of cellular immunity in systemic sclerosis pathogenesis: update on CD4+T cells population studies.
Roum Arch Microbiol Immunol
; 68(1): 5-13, 2009.
Artículo
en Inglés
| MEDLINE | ID: mdl-19507621
2.
PI3K/Akt signaling in peripheral T lymphocytes from systemic lupus erythematosus patients.
Roum Arch Microbiol Immunol
; 68(2): 69-79, 2009.
Artículo
en Inglés
| MEDLINE | ID: mdl-20361524
3.
Dysregulation of anergy-related factors involved in regulatory T cells defects in Systemic Lupus Erythematosus patients: Rapamycin and Vitamin D efficacy in restoring regulatory T cells.
Int J Rheum Dis
; 19(12): 1294-1303, 2016 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-25351606
4.
Serum levels of matrix metalloproteinases MMP-2 and MMP-9 and their tissue natural inhibitors in breast tumors.
Roum Arch Microbiol Immunol
; 63(3-4): 141-58, 2004.
Artículo
en Inglés
| MEDLINE | ID: mdl-17240786
5.
Peripheral blood lymphocytes analysis detects CD100/SEMA4D alteration in systemic sclerosis patients.
Autoimmunity
; 44(5): 427-36, 2011 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-21244334
6.
Quantification and molecular characterization of regulatory T cells in connective tissue diseases.
Autoimmunity
; 42(1): 41-9, 2009 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-18800250
7.
Roles of CD147 on T lymphocytes activation and MMP-9 secretion in systemic lupus erythematosus.
J Cell Mol Med
; 11(2): 339-48, 2007.
Artículo
en Inglés
| MEDLINE | ID: mdl-17488482
8.
MMP-9 and MMP-2 gelatinases and TIMP-1 and TIMP-2 inhibitors in breast cancer: correlations with prognostic factors.
J Cell Mol Med
; 10(2): 499-510, 2006.
Artículo
en Inglés
| MEDLINE | ID: mdl-16796815
9.
Matrix metalloproteinase-9 and its natural inhibitor TIMP-1 expressed or secreted by peripheral blood mononuclear cells from patients with systemic lupus erythematosus.
J Autoimmun
; 20(4): 323-31, 2003 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-12791318
Resultados
1 -
9
de 9
1
Próxima >
>>